Corporate News 21-Apr-22
Alembic Pharmaceuticals to declare Quarterly Result
On 2 May 2022
Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 May 2022.
Previous News
Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
( Hot Pursuit - 08-Aug-24 15:48 )
Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
( Corporate News - 18-Jun-24 18:52 )
Alembic Pharma gets USFDA nod for stroke and blood clots drug
( Hot Pursuit - 18-Jun-24 14:27 )
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
( Corporate News - 13-Aug-24 12:15 )
Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
( Hot Pursuit - 13-Aug-24 13:46 )
Alembic Pharma gets US FDA nod for heart failure-treatment drug
( Hot Pursuit - 30-May-24 14:05 )
Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
( Corporate News - 30-May-24 14:49 )
Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
( Results - Announcements 07-Nov-23 15:08 )
Alembic Pharma hits record high on USFDA nod for anti psychotic drug
( Hot Pursuit - 24-Jul-24 14:43 )
Camlin Fine Sciences Ltd leads gainers in 'A' group
( Hot Pursuit - 30-Nov-23 12:00 )
Volumes soar at Timken India Ltd counter
( Hot Pursuit - 30-Nov-23 11:00 )
Other Stories
PVV Infra to convene board meeting
05-Oct-24 10:06
Avenue Supermarts declare Quarterly Result
05-Oct-24 10:06
Fortis Healthcare to hold board meeting
05-Oct-24 10:06
Syngene International to convene board meeting
05-Oct-24 10:06
Srestha Finvest to conduct board meeting
05-Oct-24 10:06
Spright Agro schedules board meeting
05-Oct-24 10:05
Jagsonpal Finance & Leasing to table results
05-Oct-24 10:05
Hathway Cable & Datacom to hold board meeting
05-Oct-24 10:05
Bajaj Housing Finance to announce Quarterly Result
05-Oct-24 10:05
Board of NRB Bearings recommends interim dividend
05-Oct-24 09:27
Back
Top